Dunhill Financial’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,000
Closed -$1.16K 970
2024
Q3
$1.16K Buy
+5,000
New +$1.16K ﹤0.01% 767